#fda-regulations

#fda-regulations

FDA allowed compounding pharmacies a grace period to cease production post-drug shortage, but some continue to sell modified tirzepatide products.

Compounding pharmacies are suing the FDA to continue producing tirzepatide imitations despite the drug's supply improving.

The FDA announced that the tirzepatide shortage has been resolved, impacting compounding pharmacies' operations.

Obesity treatments are transforming patients' relationship with food but compounding alternatives to popular drugs face restrictions.

FDA's declaration ends availability of compounded tirzepatide, causing distress among patients who rely on it.

Federal food safety regulators warned Bimbo Bakeries USA for mislabeling allergens on their products, impacting 33 million Americans with food allergies.

U.S. health officials plan to phase out eight petroleum-based artificial colors from food, replacing them with natural substitutes.

Rizo Lopez Foods recalled products linked to a listeria outbreak that caused two deaths, leading to a federal court injunction against its operations.

The FDA has removed the only authorized use of BVO in the food supply due to safety concerns and adverse health effects.

Many beverage makers have already reformulated their products to replace BVO with alternative ingredients, with few beverages in the U.S. still containing BVO.

The FDA announces phase-out of eight synthetic food dyes, prioritizing health and transitioning to natural alternatives.

George Stone Crab operates without necessary permits and disregards food safety regulations.

Serious health risks are posed by improper monitoring of seafood handling.

Sunscreen innovation is hindered in the U.S. due to strict FDA regulations compared to other countries that approve new filters more readily.

Sunscreen is essential for skin health and safety, reducing the risk of skin cancer and premature aging.

The Super Bowl ad for Hims & Hers is under scrutiny for lacking mandatory disclosures required for pharmaceutical ads.

Compounded tirzepatide offers immediate weight-loss benefits but will soon be unavailable due to FDA restrictions.

The FDA plans to drastically reduce nicotine levels in cigarettes to prevent addiction and reduce smoking-related deaths.

Valisure, a tiny laboratory in Connecticut, has detected harmful chemicals in widely used medications, leading to product recalls and increased awareness of product safety issues.

The U.S. Supreme Court's decision prevents restrictions on nationwide access to the abortion pill mifepristone, but concerns persist over medication abortion access and FDA regulations.

The U.S. Supreme Court will review the FDA's rejection of marketing new flavored vaping products, questioning FDA's decision-making process under the Family Smoking Prevention and Tobacco Control Act.